Clinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Clinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma

Published:2016-11 Issue:11 Volume:11 Page:1879-1890
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Takada Kazuki,Okamoto Tatsuro,Shoji Fumihiro,Shimokawa Mototsugu,Akamine Takaki,Takamori Shinkichi,Katsura Masakazu,Suzuki Yuzo,Fujishita Takatoshi,Toyokawa Gouji,Morodomi Yosuke,Okano Shinji,Oda Yoshinao,Maehara Yoshihiko

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. Cancer statistics, 2012;Siegel;CA: Cancer J Clin,2012

2. Molecularly targeted therapies in non-small-cell lung cancer annual update 2014;Morgensztern;J Thorac Oncol,2015

3. New targetable oncogenes in non-small-cell lung cancer;Oxnard;J Clin Oncol,2013

4. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

5. Immune checkpoint blockade in cancer therapy;Postow;J Clin Oncol,2015

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD‐L1 expression in patients with non‐small‐cell lung cancer is associated with sex and genetic alterations: A retrospective study within the Caucasian population;Thoracic Cancer;2024-06-11

2. CD155 Expression in Early-Stage Lung Adenocarcinoma;The Annals of Thoracic Surgery;2024-06

3. Factors correlating the expression of PD-L1;BMC Cancer;2024-05-25

4. The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma;JTO Clinical and Research Reports;2024-04

5. Association of PD‐L1 expression with driver gene mutations and clinicopathological characteristics in non‐small cell lung cancer: A real‐world study of 10 441 patients;Thoracic Cancer;2024-03-08